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ABSTRACT
Histone H4 acetylation at Lysine 16 (H4K16ac) is a
key epigenetic mark involved in gene regulation, DNA
repair and chromatin remodeling, and though it is
known to be essential for embryonic development, its
role during adult life is still poorly understood. Here
we show that this lysine is massively hyperacety-
lated in peripheral neutrophils. Genome-wide map-
ping of H4K16ac in terminally differentiated blood
cells, along with functional experiments, supported
a role for this histone post-translational modification
in the regulation of cell differentiation and apoptosis
in the hematopoietic system. Furthermore, in neu-
trophils, H4K16ac was enriched at specific DNA re-
peats. These DNA regions presented an accessible
chromatin conformation and were associated with
the cleavage sites that generate the 50 kb DNA frag-
ments during the first stages of programmed cell
death. Our results thus suggest that H4K16ac plays
a dual role in myeloid cells as it not only regulates
differentiation and apoptosis, but it also exhibits a
non-canonical structural role in poising chromatin
for cleavage at an early stage of neutrophil cell death.
INTRODUCTION
Histone post-translational modifications (PTMs) play an
important role in the regulation of chromatin structure and
have been associated with the regulation of gene expres-
sion (1–3). Consequently, histone PTMs are one of the cen-
tral epigenetic modifications involved in embryonic devel-
opment and cell differentiation, as well as in pathological
conditions including cancer.
Hematopoiesis is a very dynamic spatial-temporal-
regulated process controlling the homeostasis of the
hematopoietic system throughout the entire lifespan of
an individual. It is maintained by the activity of rare
self-renewing, long-lived hematopoietic stem cells (HSCs)
which are capable of giving rise to all blood cell lineages
whereby multipotent progenitors transit multiple decision
points while becoming increasingly lineage-restricted. Loss
of such homeostasis underlies hematopoietic defects af-
fecting erythro-myeloid and lymphoid lineages, resulting in
life-threating malignancies, infections, anemia and bleed-
ing. The activation and repression of specific gene pro-
grams during hematopoiesis is highly regulated by epige-
netic mechanisms (2), PTMs playing a central role (4). One
of these histone PTMs, histone H4 acetylation at Lysine 16
(H4K16ac), can regulate the expression of HOX9 (5,6), a
gene involved in the hematopoietic commitment of embry-
onic stem cells (7). In line with this, it has been proposed
that themajorH4K16 histone acetyltransferaseKAT8 (also
known as males absent on the first (MOF), or MYST1)
(8) is central to the maintenance of hematopoietic stem
cell (HSC) target genes (9). The H4K16ac-specific NADH-
dependent histone deacetylase Sirt1 also plays an important
role in hematopoiesis (6,10), and, in addition, HDAC1 and
HDAC2, which can deacetylate H4K16ac, are highly regu-
lated during hematopoietic differentiation (11) and may be
essential for HSC homeostasis (12).
Mice carrying null mutations of Kat8 revealed that
H4K16ac is necessary for normal development and the
maintenance of normal distribution of euchromatin in
mammals (13), although accompanying molecular events
were not studied due to the very early death of the preim-
plantation embryos. At a physicochemical level, acetylation
of H4K16 was shown to regulate both higher order chro-
matin structure and functional interactions between non-
histone proteins and the chromatin fiber (14), which could
explain the biological role of this histone PTM in transcrip-
tional activation (14–16).
In addition to the regulation of hematopoietic genes,
H4K16ac has been associatedwith apoptosis and cell death,
and, specifically, to have an important role in the repression
of apoptotic genes in human cancer (17,18), which is in line
with the capacity of HDAC inhibitors to induce apoptosis
(19,20). Interestingly global levels of H4K16 acetylation are
reduced in various types of tumor (21–24), and decreased
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levels of KAT8 (23,25–29) and increased levels of HDACs
(19,30–33) are often found in cancer cells. In accordance
with this, it has been demonstrated that H4K16 acetylation
controls the sensitization of multidrug-resistant cancer cells
to topoisomerase inhibitors (34,35), supporting the notion
that this histone modification might play a general role in
apoptosis, although the underlying molecular mechanisms
involved remain elusive.
The role of H4K16ac in apoptosis might have implica-
tions in the regulation of the outcome of autophagy since
high levels of this histone PTMhave been shown to promote
cell death responses upon autophagy induction (36). In the
same vein both KAT8 and H4K16ac have been shown to
be essential in the DNA damage response and for double-
strand break repair (37), a role that may be mediated, at
least in part, by the modulation of the recruitment of DNA
damage repair proteins (38).
In this study, the initial discovery that human periph-
eral blood (PB) neutrophils are massively hyperacetylated
at H4K16 as compared to other blood cell types, including
CD34+ progenitors, CD19+ B cells, CD3+ T cells, CD15+
CD16− eosinophils and CD15+ CD16+ neutrophils, led us
to investigate in more detail, both in vitro and in vivo, the
role of this histone PTM in hematopoiesis. Our results in-
dicate that H4K16ac plays a complex role in this process,
which has implications in terms of gene regulation and,
more importantly, for the regulation of neutrophil chro-
matin structure and apoptosis. Neutrophil homeostasis is
tightly regulated by a process known as neutrophil constitu-
tive apoptosis, a type of programmed cell death that shares
many features of classical apoptosis (39,40). Although the
underlying molecular mechanisms are still not fully under-
stood, our results suggest that nuclear chromatin and, in
particular H4K16ac, may play an important role in the pro-
cess.
MATERIALS AND METHODS
Purification of peripheral white blood cells
Blood samples from 26 healthy donors and from two pa-
tients with eosinophilia resulting from asthma exacerbation
were collected from the Hospital Universitario Central de
Asturias (HUCA). The study was approved by the Clini-
cal Research Ethics Committee of HUCA and all the indi-
viduals provided written informed consent. Mononuclear
cells (MNC) and granulocytes were separated from whole
blood by density gradient centrifugation using a standard
Ficoll protocol (Histopaque-1077, Sigma-Aldrich, 10771).
After lysing red cells (BioLegend, 420301), we performed
the isolation from the MNC fraction of CD3+ T cells, and
CD15+ CD16+ neutrophils or CD15+ CD16− eosinophils
from the granulocyte fraction (eosinophils from patients),
using the corresponding selection of the AutoMACS sys-
tem (130-050-101 for CD3, 130-046-601 for CD15, 130-092-
010 for CD16) (Miltenyi Biotec). Cells were collected for
subsequent analyses. Blood samples from 18 Pelger-Hu¨et
individuals were collected at Hospital Universitario La Fe
(Valencia) with the corresponding informed consent. His-
tones were isolated from those samples for mass spectrom-
etry analysis. Another set of MNCs was isolated by density
gradient centrifugation using Ficoll-Hypaque from 20 um-
bilical cord samples collected, with Clinical Research Ethics
Committee approval, by Banc de Sang i Teixits (Barcelona).
After lysing red cells, the CD34+ cells were purified by mag-
netic bead separation using the human CD34 MicroBead
kit (130-046-703,Miltenyi Biotec) and the AutoMACS Pro-
separator (Miltenyi Biotec) as per the manufacter’s instruc-
tions and the cells collected for subsequent analyses.
High-performance capillary electrophoresis (HPCE) quan-
tification of global histone acetylation
Histone acid extraction (sulfuric acid + acetone precipita-
tion) and global histone acetylation was performed as pre-
viously described (41,42) with slight modifications. In brief,
individual fractions of histones H4, H3, H2A and H2B
were purified by reversed-phase high-performance liquid
chromatography (HPLC) on a Jupiter C18 column (Phe-
nomenex, Inc.) and eluted with an acetonitrile gradient (20–
60%) in 0.3% trifluoroacetic acid using an HPLC gradient
system (Beckman Coulter). Acetylated histone derivatives
were resolved by high-performance capillary electrophore-
sis (HPCE) using an uncoated fused-silica capillary tubing
(Beckman-Coulter; 60.2 cm × 75 m, effective length 50
cm) in a capillary electrophoresis system (P/ACE MDQ,
Beckman-Coulter) with 100 mM phosphate buffer (pH 2.0)
0.02% (w/v) HPM-cellulose as running buffer and an oper-
ating voltage of 12 kV.
Western blotting
Histones were separated on a 17% sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) and trans-
ferred to a 45-m-pore polyvinylidene difluoride (PVDF)
membrane (Immobilon PSQ, Millipore). The membrane
was blocked in 5% BSA/TBS-T (Tris-buffered saline with
0.1% Tween-20) and immunoprobed with antibodies to
acetylation at lysine 16 of histone H4 (H4K16ac) (Milli-
pore, 07–329), and using histone H3 (Abcam, ab1791) as
a loading control. The secondary antibody used was anti-
rabbit IgG conjugated to horseradish peroxidase (Amer-
sham Biosciences, NA934) at 1:3000 dilution in TBS-T. Pri-
mary antibodies were prepared for incubation in 5% BSA
in TBS-T while secondary antibody was blocked with 5%
milk in TBS-T. Signals were detected with ECL detection
kit (Amersham Biosciences). Protein bands were quanti-
fied using ImageJ software (Rasband, W.S., ImageJ, U.S.
National Institutes of Health, Bethesda, MD, USA, https:
//imagej.nih.gov/ij/, 1997–2018).
Mass spectrometry assays
Histone H4 preparation for mass spectrometry. Bands cor-
responding to histone H4 were excised from SDS-PAGE
gels and processed as previously described (43) with mi-
nor modifications. Briefly, after destaining the gel pieces
with 0.1 M ammonium bicarbonate in 30% HPLC-grade
acetonitrile, samples were washed twice with 70% HPLC-
grade methanol and acylated at RT with propanoic anhy-
dride. To this end, 15 l 0.71 M propanoic anhydride in
70% methanol was added to each sample and, after 2.0 min
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incubation at RT, 40 l 1M ammonium bicarbonate was
added to each crude. Reactions were kept at RT for a fur-
ther 15 min, then the gel pieces were washed again with 70%
methanol and the acylation was repeated once more. Next,
the gel pieces were washed sequentially with 0.1 M ammo-
nium bicarbonate, water, 50% acetonitrile, and then shrunk
with 100% acetonitrile. Proteins were then digested over
night at 37◦Cwith 0.26g trypsin (Trypsin Gold, Promega)
per sample, according the manufacturer’s instructions.
Analysis of H4 acetylation by MALDI-TOF/TOF mass
spectrometry. Three 1 l and three 0.5 l aliquots of
each crude were spotted onto a stainless steel MALDI tar-
get plate, allowed to dry, overlaid with 0.5 l freshly pre-
pared, ice-cold 5 mg/ml alpha-cyano-4-hydroxy cinnamic
acid (ultra-pure, for mass spectrometry, Fluka) in 50%
acetonitrile/0.3% TFA, and then dried again. Spectra were
recorded in a MALDI-TOF/TOF instrument (4800, Ap-
plied Biosystems) operated according to the manufacturer’s
instructions. MS1 spectra were acquired in the reflector
modus, setting the m/z window between 700 and 2500 and
the focus on 1500, with 20 sub-spectra (50 shots each) being
collected per spot. Tandem spectra (MS2) of the unmod-
ified and monoacetylated forms of the peptide 4–17 were
recorded with 1 kV collision energy without the use of col-
lision gas (CID off), with the isolation window width set to
2.0 Da, and 55 sub-spectra (50 shots of each) were collected
per spot. For allMS andMS/MS spectra, the laser intensity
was manually adjusted for a good S/N.
MS1 spectra were processed with mMass 5.5.0 (44,45).
Each spectrum was recalibrated by using the signals of pep-
tides 46–55 and 79–92 and deisotoped. Next, the relative
proportion of a given form of the peptide 4–17 was calcu-
lated by dividing the absolute intensity of its monoisotopic
peak by the sumof the intensities of themonoisotopic peaks
corresponding to the unmodified, mono- and diacetylated
peptide 4–17. Finally, the results for all the spectra acquired
from each sample were averaged and minimum and maxi-
mum values were extracted.
Generation of a conditional Kat8-deficient mouse model
A targeting construct for the Kat8 locus was created
through a previously described recombineering-specific
methodology (46). Briefly, loxP sites were introduced be-
tween exons 1 and 2, and between exons 5 and 6. This
resulted in a mouse strain in which bases 2373–8550 (in-
corporating exons 2–5) 3′ from the start point of trans-
lation, could be deleted leaving a single loxP site be-
tween exons 1 and 6 (13). These mice were crossed with a
CreERT2 strain which allowed the removal of exons 2–5 in
a tamoxifen-dependent manner (47). Mice were maintained
on a C57BL/6 background, fed ad libitum, and housed un-
der a 12-h light-dark cycle. PCR genotyping was performed
using the oligonucleotides in Supplementary Table S1. The
PCR products consisted of fragments of 422 bp (WT allele),
509 bp (floxed allele) and 277 bp (excised allele).
Animal experiments were conducted in accordance with
the guidelines of the Committee for Animal Experimenta-
tion of the Universidad de Oviedo. To induce Kat8 dele-
tion, tamoxifen (Sigma-Aldrich, T5648) was administrated
by oral gavage at a dose of 6 mg tamoxifen/40 g body
weight for a total of 7 days. For hematological determi-
nations, blood was extracted from the mandibular sinus of
mice anesthetized with isoflurane. Blood samples were an-
alyzed using Abacus junior vet equipment (Diatron Labs).
Details of the in vitro murine neutrophil differentiation
assays and the subsequent analyses are available in Supple-
mentary Materials and Methods.
ChIP-seq
For high-throughput sequencing of H4K16ac-enriched ge-
nomic regions (ChIP-seq), CD3+ T cells and neutrophils
isolated from human peripheral blood of 5 donors (Sup-
plementary Table S2) were freshly processed using the Sim-
pleChIP Enzymatic Chromatin IP Kit (Magnetic Beads)
(Cell Signaling, 9003). The amount of Microccocal Nu-
clease required to digest DNA to the optimal length was
determined as 2.5 l per 2 × 107 cells. Library prepara-
tion and sequencing were performed at Centre de Regulacio´
Geno`mica (CRG) in Barcelona on an Illumina HiSeq 2000
system in 50-single end mode.
A detailed description of the bioinformatic analysis of
Chip-seq data is available in Supplementary Materials and
Methods.
Cell culture and in vitro treatments of HL60 cell line
The human HL-60 cell line was grown in Gibco RPMI
1640medium supplementedwith 10%FBS (Sigma-Aldrich,
F6178), 100 U/ml penicillin along with 100 g/ml strep-
tomycin (Gibco, 15070) and 2.5 g/ml amphotericin B
(Gibco, 15290) at 37◦C in a humidified atmosphere with 5%
CO2.
Differentiation was induced by treatment with 1 M
ATRA (Sigma-Aldrich, R2625) and/or 1.25% DMSO
(Sigma-Aldrich, D5879) for 72 h. Etoposide (Sigma-
Aldrich, E1383) treatment was carried out at a concentra-
tion of 5 and 10 M and cells were collected after 1, 2, 3,
4 and 5 h for the lower or 1, 2 and 3 h for the higher con-
centration. Treatment with the HDAC inhibitor SAHAwas
carried out at 1 M for 48 h. The KAT8 overexpression
vector was generated as previously described (48). Opti-
MEM (Gibco, 31985) and Lipofectamine 3000 transfec-
tion reagent (Invitrogen Corp., L3000015) were used for the
transient transfection of plasmid DNA. shKAT8 lentiviral
expression vectors were obtained from OriGene (Rockville,
MD). The cells were collected 72 h after transfection.
Apoptosis related to Annexin V detection was deter-
mined using the FITC Annexin V Apoptosis Detection
Kit with 7-AAD (BioLegend, 640922) or the antibody Dye
634 Annexin V (Immunostep, ANXVDY) depending on
the experiment, using a Facs Aria IIu flow cytometer and
FACSDiva v8.02 software (Becton Dickinson) Cell cycle
phases and debris percentage were analyzed using propid-
ium iodide (Sigma-Aldrich, P4170) as previously described
(49,50). Data were acquired using a Cytomics FC500 Flow
Cytometer (Beckman Coulter) and analyzed using CXP
Software (Beckman Coulter 2006) andModFit LT 3.0 (Ver-
ity Software House).
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Quantitative real-time reverse transcriptase polymerase
chain reaction (qRT-PCR)
Cells for RNA extraction were pelleted and immediately
frozen in dry ice. Storage was performed at -80◦C. To-
tal RNA was isolated using TRIzol Reagent (Life Tech-
nologies, Ref. 15596) following manufacturer´s instruc-
tions. Chloroform (Ref. 1.02445.100) was purchased from
Merck; and isopropanol (Ref. 1.09634.100) and ethanol
(Ref. 100983) from Merck-Millipore. To remove any pos-
sible contamination by DNA, 10 ug of total RNA were
treated with DNase I (Turbo DNA-free kit, Ambion-Life
Technologies, Ref. AM1906) according to supplier’s proto-
col.
RNA was quantified both before and after DNase treat-
ment with Nanodrop (ThermoScientific) checking purity
as A260/280 ratio. One microgram of total DNA-free
RNA was reverse-transcribed in 20 ul of final reaction vol-
ume using Oligo(dT)12–18 Primer (Invitrogen, Ref. 18418)
and dNTP Mix (Invitrogen, Ref. 18427) in combination
with SuperScript™ III Reverse Transcriptase (Invitrogen,
Ref. 18080) and RNaseOUT™ Recombinant RNase In-
hibitor (Invitrogen, Ref. 10777). After cDNA synthesis, 1
l (2 units) of E. coli RNase H (Invitrogen, Ref.18021) was
added and each sample was incubated at 37◦C for 20 min to
finally remove RNA complementary to the cDNA. All the
process was performed following the instructions detailed
for SuperScript™ III RT (Invitrogen, Ref. 18080).
Real-time PCRwas carried out for each sample of cDNA
using 2× SYBR Green PCR Master Mix (Applied Biosys-
tems, 4309155). All measurements were performed in trip-
licate, non-template controls were included, and a calibra-
tion curve was determined for each primer set. PCR reac-
tions were run and analyzed using the StepOnePlus™ Real-
Time PCR System (Applied Biosystems). Gene expression
was normalized using GAPDH as endogenous control for
human samples (51) and beta Actin for mouse samples and
analyzed by the comparative threshold (Ct) method.
All primers were acquired from Sigma-Aldrich. Oligonu-
cleotide sequences are listed in Supplementary Table S1.
CB collection and CD34+ HSPC isolation for KAT8 down-
regulation on human primary cells
Fresh umbilical cord blood (CB) units from healthy
neonates were obtained from the Banc de Sang i Teixits,
Barcelona, upon approval by the Ethics and Biohazard
Board Committee. CB samples were pooled to reduce vari-
ability among individual CB units. Mononuclear cells were
isolated using Ficoll-Hypaque and after lysing the red cells
(Cytognos, Salamanca, Spain), CD34+ cells were purified
by magnetic bead separation using the human CD34 Mi-
croBead kit and the AutoMACS Pro separator (Miltenyi
Biotec, Bergish Gladbach, Germany) as per manufacturer’s
instructions (52–54). Purity of the CD34+ fraction was as-
sessed by flow cytometry using anti-CD34-PE (BD Bio-
science, San Jose, CA, USA) and only CD34+ fractions
showing purity >95% were used (52,53).
Details of the KAT8 down-regulation (shKAT8) assays
in human CD34+ progenitors and the subsequent analyses
following induction of neutrophil differentiation are avail-
able in Supplementary Materials and Methods.
Pulsed field gel electrophoresis
Temperature-dependent induction of synchronous neutrophil
apoptosis. For the arrest of neutrophils and the subse-
quent induction of synchronous apoptosis, we followed
the protocol described by Pryde et al. (55) with minor
modifications. Briefly, neutrophils were cultured in T75
flasks (Corning) at 1 × 106 cells/ml in Gibco RPMI
1640 growth medium supplemented with 100 U/ml peni-
cillin and 100 g/ml streptomycin (Gibco), 250 g/ml
amphotericin B (Gibco), 10% (v/v) autologous serum,
25 mM HEPES (Merck), 0.2% (w/v) albumin from bovine
serum (BSA, Sigma-Aldrich), and 20 g/ml cycloheximide
(Sigma-Aldrich). After incubation at 15◦C for 20 h, neu-
trophils underwent apoptosis synchronously when the tem-
perature was raised to 37◦C. The cells for the preparation of
agarose plugs were collected 2 h after the temperature shift.
Preparation of agarose plugs and Pulsed Field Gel Elec-
trophoresis (PFGE). CD15+ CD16+ neutrophil DNA
embedded in agarose plugs was prepared as follows: about 5
× 106 cells for each 100 l of agarose plug to be made were
collected, washed once with 1× PBS (Oxoid), and resus-
pended in 35 l of 50 mM EDTA (Merk), 10 mM Tris (pH
7.5) (Roche). The suspension was quickly warmed at 42◦C
and mixed with 65 l of prewarmed 1% low melt agarose
(NuSieve GTGLowMelting Temperature Agarose, Lonza)
and 125 mM EDTA. The suspension was distributed into
well plug molds placed on a cool surface. The plugs were
extruded and incubated overnight at 53◦Cwithout agitation
in 600l of 500mMEDTA, 10mMTris (pH 8.0), 1% (w/v)
N-Laurylsarcosine (Sigma-Aldrich), and 0.4 mg/ml Pro-
teinaseK (Roche). Plugs were soaked for 1 h three times in 1
ml of 50 mM EDTA, and 10 mM Tris (pH 7.5). As positive
controls, 50kb random fragments from a pool of samples
were prepared as follows: concentrations of genomic DNA
fromneutrophils were determinedwith aQubit 2.0 fluorom-
eter (Life Technologies). About 4 g of DNA from each
sample was sonicated using a Bioruptor UCD-200 sonica-
tion device (Diagenode) performing for 2–4 min bursts in
low power mode in order to shear the DNA into 50 kb frag-
ments. Sonicated samples were subjected to PFGE in liquid
form under the same running conditions described above.
Pulsed field electrophoresis was carried out in a 0.9%
agarose gel (D5 agarose, Conda) in 0.5× TBE at 14◦C with
a CHEF DR III from Bio-Rad with a switch time ramping
from 5 to 30 s over a 22 h period, to resolve fragments from
20 to 400 kb. Lambda ladder was used as size marker for
PFGE (New England Biolabs). For DNA extraction, the
portion of the gel containing the 50 kb DNA fragments of
interest was excised. The agarose was melted at 55◦C and
the DNA extracted using the QIAEX II Gel Extraction Kit
(QIAGEN).
Bisulfite pyrosequencing
DNAmethylation patterns of Alu repetitive sequences were
analyzed by bisulfite pyrosequencing in neutrophils and
CD3+ T cells. Bisulfite modification of DNA was per-
formed with the EZ DNA methylation-gold kit (Zymo Re-
search) following the manufacturer’s instructions. The set
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of primers for PCR amplification and sequencing were de-
signed using the specific software PyroMark assay design
(version 2.0.01.15) (Supplementary Table S1). After PCR
amplification, pyrosequencing was performed using Pyro-
Mark Q24 reagents and a vacuum prep workstation, equip-
ment, and software (Qiagen).
Immunofluorescence
For immunofluorescence experiments 2× 105 cells were ad-
hered to slides by Cytospin centrifugation (Thermo Scien-
tific). Samples were fixed with 4% formaldehyde for 15 min
at room temperature, and permeabilized with 1× PBS/0.1%
Triton X-100 (X100 Sigma-Aldrich) for 20 min at room
temperature. Blocking was performed with 1× PBS/10%
BSA (A7906 Sigma-Aldrich) for one hour at room tempera-
ture, followed by incubation with the primary antibody rab-
bit anti-H4K16ac (07-329, Merck Millipore) at 1:500 dilu-
tion in antibody diluent (EnVision FLEX DM830 Dako),
O/N at 4◦C. Secondary antibody chicken anti-rabbit IgG
Alexa Fluor 488 (A-21441 Invitrogen) at 1:500 dilution, was
incubated for 1 h at room temperature and protected from
light. Finally, slides were mounted using EverBrite mount-
ing medium with 4′,6-diamidino-2-phenylindole (DAPI)
(23002 Biotium).
Immunofluorescence images were obtained using a Zeiss
microscope equipped with a 63×/1.4 NA immersion lens,
and an AxioCam MRm camera (Carl Zeiss). DAPI and
H4K16ac images were acquired sequentially for a total
of 10 z-sections (Z step of 5 m) with at the appropri-
ate emission wavelengths. Fluorescence intensity measure-
ments were performed using the ZEN lite software (ZEN
lite 2.3 SP1, Carl Zeiss).
For immunofluorescence analysis of HL60 confluence
experiment, cells were fixed in acetone at −20◦C for
20 min, washed with PBS, and incubated with primary
antibodies overnight at 4◦C at 1:100 dilutions. Next,
fluorescent-conjugate secondary antibodies (Alexa fluor
488–conjugated goat anti-rabbit IgG from Serotec and
CyTM3-conjugated donkey anti-mouse antibody from
Jackson-ImmunoResearch) at 1:100 dilution were added
to the fixed cells, which were then incubated for 1 h at
room temperature in a darkened humidity chamber. Finally,
samples were counterstained and mounted with DAPI (10
ng/ml; Sigma-Aldrich) diluted 1:1000 in fluoromount G
(SouthernBiotech). Confocal immunofluorescence micro-
graphs were captured with a TCS-SP2-AOBS confocal mi-
croscope (Leica Microsystems).
Chromatin accessibility assay
For the analysis of chromatin accessibility in multiple repet-
itive elements, 1 × 106 CD15+ CD16+ neutrophils and 1 ×
106 CD3+ lymphocytes from four donors were subjected to
chromatin extraction and nuclease digestion according to
manufacturer’s instructions (EpiQuik Chromatin Accessi-
bility Assay kit, P-1047 Epigentek). Purified DNAwas ana-
lyzed via real time qPCR using primers for different repeats
(see Supplementary Table S1). Fold enrichment (FE) was
calculated as the ratio of amplification efficiency (Ct) of the
digested DNA sample over that of the non-digested sample.
Large Ct shifts between digested and undigested samples,
rendering high FE%, indicated that the target region was
in the open chromatin, while minimal Ct shifts, resulting in
low FE%, indicated that the target region was in the closed
chromatin.
Formaldehyde-Assisted isolation of regulatory elements
(FAIRE) quantitative PCR (FAIRE-qPCR)
For the FAIRE analyses we followed the protocol for sus-
pension cells described by Simon et al. (56,57), using 1× 107
CD15+ CD16+ neutrophils and 1× 107 CD3+ lymphocytes
from four different healthy donors as starting material. The
enriched fragments were detected by real time qPCR using
primers for different repeats (see Supplementary Table S1).
Histological analysis
Mouse tissues were fixed in 4% buffered paraformaldehyde
solution. Paraffin sections were stained with hematoxylin
and eosin. The May-Gru¨nwald-Giemsa staining procedure
was followed to study human blood smears.
Chromatin immunoprecipitation assays and real-time PCR
quantification (qChIP)
For the preparation of crosslinked chromatin, fresh samples
were incubated in PBS with 1% formaldehyde for 10 min
at RT. Crosslinking was stopped by the addition of glycine
to 125 mM, and cells were washed in PBS. All subsequent
procedures were performed on ice, with buffers contain-
ing the protease inhibitors (Complete EDTA-free) as pre-
viously described (58). Sonication yielded chromatin frag-
ments of 150–500 bp in length. Immunoprecipitations were
performed using antibodies against H4K16ac (Active Mo-
tif, 39167), total histone H3 (Abcam, ab1791) as positive
control, or IgG antiserum (Abcam, ab46540) as negative
control.
After testing the PCR amplification sensitivity of
primers, quantitative real-time PCR analysis was per-
formed for each specific region using SYBR® Green of the
StepOnePlus™ Real-Time PCR System (Applied Biosys-
tems). All measurements were performed in triplicate, non-
template controls were included, and a calibration curve
was determined for each primer set. Three independent ex-
periments were tested for each sequence. Oligonucleotide
sequences are listed in Supplementary Table S1.
Heat density scatterplots
Two-dimensional kernel density estimations were gener-
ated with the Bioconductor R-package MASS (7.3–47).
H4K16ac and DAPI signals were normalized by the maxi-
mum intensities obtained for each of the experiments prior
to the computation step. The resulting data comprised 9198
and 5925 pairwise data points (H4K16ac and DAPI nor-
malized intensities) across longitudinal sections of the cell
corresponding to observations from neutrophils (n= 72) or
CD3+ cells (n = 62), respectively.
D
ow
nloaded from
 https://academ
ic.oup.com
/nar/article-abstract/47/10/5016/5421813 by U
niversity of N
ew
castle user on 24 June 2019
5022 Nucleic Acids Research, 2019, Vol. 47, No. 10
RESULTS
Global H4K16 hyperacetylation in PB neutrophils
To study the possible role of H4K16ac in the hematopoi-
etic system we first used HPLC and HPCE to analyze the
global levels of H4 acetylation in different human blood
cell types. Intriguingly, we found a 1.7-fold relative increase
in the monoacetylation of H4K16 in neutrophils (CD15+
CD16+) compared with CD3+ T cells, which, in absolute
terms, implies an increase in H4K16ac in over 20% of the
neutrophil genome (Figure 1A). Analysis of other acety-
lated forms of H4 (59), showed that the relative percentage
of diacetylated isoforms (where Lysine 12 and 16 are acety-
lated) was slightly lower in neutrophils (Supplementary Fig-
ure S1A), and tri- and tetracetylated isoforms (where, re-
spectively, Lysines 8, 12 and 16 or Lysines 5, 8, 12 and 16
are acetylated) were not detected in blood cells with this
technology. Histone H3 and histone H2B did not show any
substantial changes in global acetylation between CD15+
CD16+ and CD3+ T cells (Supplementary Figure S1B).
As it had been previously reported that the majority of
histone H4 monoacetylation occurs at H4K16 (60,61), we
hypothesized that the global H4 acetylation changes we ob-
served primarily occur at this position. To test this, we used
two different approaches. First, we used Western Blotting
to analyze the levels of H4K16ac and H4K12ac in sev-
eral blood cell types, including those previously analyzed
by HPLC/HPCE, using antibodies against these histone
PTMs. K12 is another lysine residue that has been reported
to be acetylated in histone H4 (60,61). The results showed
an enrichment of H4K16ac (Figure 1A, and Supplemen-
tary Figure S1C) but not of H4K12ac (Supplementary Fig-
ure S1d) in neutrophils (CD15+ CD16+), suggesting that,
the observed global histone H4 acetylation changes pri-
marily did occur at K16. To corroborate this further, we
used mass spectrometry to analyze the levels of H4K16ac
in five types of blood cells (CD34+ hematopoietic progeni-
tors, CD19+, CD3+, CD15+ CD16− and CD15+ CD16+).
The integration of the signals corresponding to the pep-
tide 4–17 confirmed that the global levels of monoacety-
lated histone H4 were much higher in myeloid cells than in
CD34+ hematopoietic progenitors and B and T cells (Fig-
ure 1B). In addition, tandem mass spectrometry revealed
that, in all samples analyzed, the great majority of his-
tone H4monoacetylation occurred at lysine 16 (Figure 1C),
thus confirming that H4K16ac is highly regulated in the
hematopoietic system.
Genome-wide differential distribution of H4K16ac in termi-
nally differentiated blood cells
To study the role of H4K16ac in blood cells in more de-
tail, we determined the genome-wide distribution of this hi-
stonemark in humanCD3+ T cells and neutrophils (CD15+
CD16+) combining chromatin immunoprecipitation, tar-
geting this histone mark with high-throughput sequencing
(ChIP-seq) (see Materials and Methods).
We generated over 200 million 50-base paired-end reads
from H4K16ac enriched and input (control) libraries of
CD3+ T cells and neutrophils (Methods, and Supplemen-
tary Table S2). Of these raw reads, 191 640 570 (77.33%) in
CD3+ cells and 164 229 168 (73.46%) in neutrophils were
aligned to one or the other strand of the reference genome
(GRCh37/hg19) (Supplementary Table S2). In addition to
the unique alignments, other reads aligned in multiple posi-
tions (multi-reads or ambiguous reads) (Supplementary Ta-
ble S2). Similar counts were obtained in four additional in-
dependent biological replicates (Supplementary Table S2).
To identify H4K16ac enriched regions (peaks) we used
theModel-basedAnalysis of ChIP-seq (MACS2) algorithm
(62), and the corresponding inputs as control samples (see
Materials and Methods). We identified a total of 229 474
peaks in CD3+ cells, and 266 860 peaks in neutrophils (Fig-
ure 2A; Supplementary Tables S3 and S4). The peak size
differed significantly between the two cell types (Wilcoxon
rank sum test, P < 2.2e–16): CD3+ showed a median peak
size of 615 bp, while that of neutrophils was 2.29 kb (Fig-
ure 2A). Consequently, the total length of neutrophil peaks
was 611 116 535 bp, covering 19.48 % of the genome, and
for CD3+ T cells it was 150 618 607 bp, accounting for
only 4.8 % of the genome (Figure 2A). This higher cover-
age by peaks in neutrophils than in T cells was evident in
all chromosomes (Supplementary Figure S2A), confirming
the genome-wide level of the global differences between spe-
cific blood cell types observed by HPLC/HPCE and mass
spectrometry.
To study the associations between H4K16ac ChIP-seq
peaks and genomic features we determined their distribu-
tion throughout the genome. We found that peaks of neu-
trophils were located in regions with higher CpG densi-
ties than those corresponding to the peaks of CD3+ T cells
(Wilcoxon rank sum test, P < 2.2e–16) (Figure 2B), irre-
spective of the chromosome analyzed (Supplementary Fig-
ure S2A). In line with these results, neutrophil peaks were
located preferentially onCpG islands andGpG shores (Per-
mutation tests, P < 0.01, FC CI = [1.32, 1.43] and P <
0.01, FCCI= [1.92, 2.06] respectively) (Supplementary Fig-
ure S2B). Interestingly, a detailed analysis of the relative
genomic distribution of ChIP-seq peaks showed a signifi-
cant overlap between neutrophil peaks and promoter and
intragenic regions (Permutation tests, P < 0.01, FC CI =
[1.50, 1.61], andP< 0.01, FCCI= [1.28, 1.35] respectively).
However, the overlap at intergenic regions was lower than
expected in both cell types, and this effect was more pro-
nounced in CD3+ T cells (Permutation tests, P < 0.01, FC
CI = [0.69, 0.72] and P < 0.01, FC CI = [0.75, 0.77] re-
spectively) (Figure 2c). Similar results were obtained in four
additional independet biological replicates (Supplementary
Figure S3).
Further analysis of H4K16ac peaks identified high num-
bers of associated genes in both neutrophils and T cells
(Figure 2D; Supplementary Figure S4; Supplementary Ta-
bles S3 and S4). Although the number of common peak-
associated genes was high, the genic sequences (in bp) en-
riched in H4K16ac were cell-type specific, and only 4.2%
of the total were common to both CD3+ T cells and neu-
trophils (Figure 2E).
To find the relationship between H4K16ac and other hi-
stone marks in neutrophils, we trained a 12 state model
with ChromHMM (63). We identified histone mark com-
binations reflecting different functional chromatin states
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Figure 1. Global H4K16ac level in different types of blood cell. (A) Global H4 monoacetylation analyzed by HPLC and HPCE in neutrophils (CD15+
CD16+) and CD3+ T cells. Error bars represent standard deviation ***P-value <0.001. On the right, western blot comparing H4K16ac in CD3+ T cells
versus neutrophils. H3 was used as loading control. The intensity (relative units) of H4K16ac bands were normalized to H3 and quantified using ImageJ
software (numbers below the bands). (B) Levels of monoacetylated histone H4 analyzed by MALDI-TOF in the hematopoietic cells. The error bars
indicate the maximum and minimum values obtained from six spectra per sample (technical replicates). (C) Fragment spectra showing that acetylation
of the peptide 4–17 primarily occurs on K16 in the samples indicated. The left panel is a zoom of the region encompassing the y4 fragment ion and its
acetylated form, while the right panel plots the region corresponding to b9 and its acetylated form. In both panels, the upper spectrum corresponds to the
unmodified peptide 4–17 (positive control for y4), the others are the fragment spectra of the monoacetylated peptide 4–17 of the samples indicated. The
detection of acetylated y4 but not its unmodified form, as well as the detection of only unmodified b9 indicate that it is mostly K16 that is acetylated. *:
impurity.
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Figure 2. Genomic distribution of H4K16 acetylation in neutrophils and CD3+ T cells. (A) Bar plot showing the number of H4K16ac-enriched peaks
identified by ChIP-seq in neutrophils and CD3+ T cells. On the right, a violin plot shows the distribution of the peak size in both cell types, and a bar
plot shows the total coverage of the genome in base pairs (bp). (B) Box plot showing the genomic distribution of CpG density for the H4K16ac-enriched
peaks in both cell types. Dotted red line represents average CpG density in the genome. (C) Bar plots showing the overlap between H4K16ac-enriched
peaks and different genomic regions in both neutrophils and T cells. Violin plots represent a permutation-based null distribution for the specific genomic
region overlap ratio for each peak data set. (D) Representative ChIP-seq tracks for H4K16ac in neutrophils and CD3+ T cells. Peaks showing fold change
above 1.5 are underlined below the profiles. The RefSeq genes track is shown below. (E) Euler diagrams showing the overlap between peaks of neutrophils
and CD3+ T cells, for both the whole genome and the different genomic regions. (F) ChromHMM training of a 12-chromatin states model (left panel) in
neutrophils. The central panel shows the enrichment of each of the 12 chromatin states in different genomic features. The right panels show the percentage
of neutrophil-specific segments for two neutrophil Blueprint samples (C0010KH2 and C0011lH2).
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(Figure 2F). Interestingly, despite the fact that H4K16ac
had a higher correlation with enhancers and actively tran-
scribed states, we identified a specific chromatin state char-
acterized by the presence of H4K16ac alone (state 10). This
was one of the most extensive chromatin states (Supple-
mentary Figure S5) and it was enriched in CpG hyper-
methylated regions (Figure 2F). After segmentation with
ChromHMM, 7.71 % of the bins (segment of 200 bp con-
taining H4K16ac) were unique to neutrophils, in concor-
dance with results shown in Figure 2A, and the majority of
which overlapped with states 9 and 10, characterized by the
presence and absence of H4K16ac respectively (Figure 2F).
H4K16ac and KAT8 play a role in hematopoietic differenti-
ation
To determine whether H4K16ac changes between different
types of blood cells reflects a role of this histone PTM in
hematopoietic cell differentiation, we first generated an in-
ducible Kat8 knockout mouse model by crossing “floxed”
Kat8 mice with tamoxifen-inducible ubiquitous Cre mice
(Kat8fl/fl;ER-Cre mice), KAT8 being the principal H4K16
acetyltransferase in mammals (8). Tamoxifen administra-
tion (Figure 3A) induced the excission of LoxP-flanked re-
gion of Kat8 (Supplementary Figure S6A), and 1 week
after the start of the treatment these mice began to lose
weight (Figure 3B), and died after three weeks (Figure 3C).
The precise cause of death was unclear. However, post-
mortem pathological examination of the Kat8−/−;ER-Cre
mice identified an evident decrease in the size of the spleen,
thymus, and liver (Figure 3D). At the microscopic level,
all the samples analyzed showed major tissular alterations
(Supplementary Figure S6B). To determine the effects of
Kat8 deletion in the blood compartiment, we analyzed the
levels of peripheral blood cell types using a hematology an-
alyzer (Abacus). This showed that tamoxifen administra-
tion markedly reduced the number of white blood cells of
Kat8−/−;ER-Cre mice (Figure 3E), affecting both myeloid
and lymphoid lineages. Moreover, Kat8 deletion inverted
the percentage of myeloid and lymphoid cells present in the
blood compared to controls (Figure 3F), suggesting a pos-
sible role of Kat8 in blood cells survival.
To study in more detail the possible role of KAT8 and
H4K16ac in the regulation of myeloid differentiation we
also compared in vitro differentiation to neutrophils of
murine cKit+ progenitors sorted from bone marrow from
Kat8fl/fl; ER-Cre and Kat8+/+;ER-Cre mice. Kat8 excision
was induced in vitro by incubating with 4-OH-tamoxifen re-
ducing Kat8 expression and H4K16ac (Figure 3G and H).
Differentiation was confirmed by May Gru¨nwald-Giemsa
staining (Figure 3I), and the levels of the two neutrophil ter-
minally differentiated markers were quantified and showed
lower levels of expression in KO cells (Figure 3J).
To determine whether KAT8 and H4K16ac were also
involved in hematopoietic differentiation in humans, we
knocked down KAT8 (shKAT8) in CD34+ progenitors ob-
tained from umbilical cord blood (Supplementary Figure
S7A) and analyzed clonogenic potential as measured by
the ability to form colony formation units (CFUs). KAT8
downregulation induced a global decrease of H4K16ac
(Supplementary Figure S7B). We did not find any dif-
ferences in proliferation potential between the scramble
and shKAT8 cells (Supplementary Figure S7C). How-
ever shKAT8 cells showed a decresase in the potential of
their hematopoietic progenitor to generate CFUs, as well
as changes in CFU distribution (Supplementary Figure
S7D). Specifically, we observed a decrease in the percent-
age of CFUs of erythrocytes, granulocytes and mixed cells,
and an increase in CFUs of granulocyte–macrophage and
macrophages (Supplementary Figure S7E).
To confirm the role of H4K16ac in the regulation of
myeloid differentiation we analyzed the levels of this epige-
netic mark in the human acute promyelocytic leukemia cell
line HL60 incubated with all-trans retinoic acid (ATRA)
and dimethylsulfoxide (DMSO), two drugs that can induce
neutrophil differentiation in both hematopoietic progeni-
tors (64) and myeloid cancer cells (65,66). In line with pre-
viously published data (21–24) the cancer cells showed a
lower H4K16 acetylation level than their non-tumorigenic
terminally differentiated perihperal blood cell counterparts
(Supplementary Figure S8A). The analysis of the expres-
sion levels of neutrophil cytosol factor 1 (NCF1) indicated
that combined treatment with ATRA and DMSO induced
the greatest degree of neutrophilic differentiation in HL60
cells (Supplementary Figure S8B). Supporting this, im-
munoflurorescent staining revealed that most of the HL60
cells treated with ATRA and DMSO acquired the lob-
ulated nuclear shape typical of neutrophils (Supplemen-
tary Figure S8C). However, the HPLC/HPCE analysis of
global histone H4 monoacetylation showed no significant
differences of cells after differentiation with ATRA and
DMSO (Supplementary Figure S8D), and this was con-
firmed by mass spectrometry (Supplementary Figure S8E).
In addition we performed a ChIP-seq analysis to deter-
mine the locus-specific changes in H4K16ac during HL60
neutrophilic differentiation induced by ATRA and DMSO
(Supplementary Table S2), and confirmed that only minor
global changes occurred (overlapping test; P < 0.005; see
Methods) (Supplementary Figures S8F and G, and Sup-
plementary Tables S5 and S6). We found that H4K16ac
was enriched in many GO terms of biological processes
related to development and differentiation in both HL60
and in vitro HL60 differentiated cells (FDR < 0.1) (Sup-
plementary Table S7). Interestingly, the small differences
(genes associated with H4K16ac specific peaks) between
control and differentiated cells were related to, among oth-
ers, ontology terms such us cell development or regulation
of signaling (FDR < 0.1) (Supplementary Tables S8 and
S9), which indicates that the absence of global H4K16ac
changes measured by mass spectrometry is compatible with
minor locus-specific H4K16ac changes, and also that locus-
specific H4K16ac may play a role in the regulation of
hematopoietic genes during in vitro differentiation of HL60
cells. Collectively, these results suggest that, in HL60 cells,
neutrophilic differentiation can be achieved, at least in part,
without the global hyperacetylation of H4K16, and that
locus-specific changes in H4K16ac during hematopoietic
differentiation do not contribute significantly to the global
changes of this histone PTM that are observed by mass
spectrometry in terminally differentiated neutrophils (Fig-
ure 1).
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Figure 3. Role of H4K16ac in peripheral white blood cells. (A) Diagram showing the timeline for tamoxifen administration in Kat8fl/fl mice with and
without the inducible ubiquitous Cre (Kat8fl/fl (n: 5) andKat8fl/fl;ER-Cre (n: 8)). (B)Weight evolution of control andKat8−/−;ER-Cremice after tamoxifen
treatment. (C) Kaplan–Meier survival curve showing that Kat8−/−; ER-Cre mice (red line) differs significantly from Kat8fl/fl mice (blue line) (P-value =
0.0011, Kaplan–Meier log-rank test). (D) Representative images of spleen, thymus, and liver from Kat8fl/fl and Kat8−/−;ER-Cremice showing differences
in the size of the organs. Line plots showing (E) differences in total number of white blood cells and (F) percentage of lymphoid and myeloid cells between
Kat8fl/fl; ER-Cre and Kat8−/− mice after tamoxifen treatment. (G). Genotype analysis of Kat8 locus using PCR specific primers on genomic DNA from
Kat8+/+;ER-Cre (pool, n: 3) as well as Kat8−/−;ER-Cre (pool, n: 3) mice cells after tamoxifen treatment. The double band indicating approximately 30%
excision of Kat8 was only detected in mice containing the floxed alleles after treatment with tamoxifen. On the right, RT-qPCR showing downregulation
of Kat8 in the cKit+ progenitors. Expression levels determined by real time-qPCR are an average of triplicated measurements (+SD), normalized to
transcript levels of beta Actin, and represented as a fold-change relative to the Kat8+/+;ER-Cre control (a t-test showed significant differences; ***P <
0.001). (H) Representative immunofluorescence images showing lower levels of H4K16ac in Kat8−/−;ER-Cre. AverageH4K16ac fluorescence intensity was
quantified using ZEN lite software (a t-test showed significant differences; **P< 0.01). (I) May Gru¨nwald Giemsa stain (40×) after in vitro differentiation
to neutrophils (day 7). (J) Expression of two markers (Collagenase andGelatinase) of neutrophilic differentiation (Pham, C., Nature Reviews Immunology,
2006) (day 7). Expression levels determined by real time-qPCR are an average of triplicated measurements (+SD), normalized to transcript levels of beta
Actin, and represented as a fold-change relative to the Kat8+/+;ER-Cre control (a t-test showed significant differences; **P < 0.01, ***P < 0.001).
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H4K16ac level is functionally associated with apoptosis in
myeloid cells
As locus-specific H4K16ac changes in hematopoietic genes
during HL60 cell differentiation did not seem to have a
substantial impact on global H4K16ac level, the regulation
of hematopoietic cell differentiation was considered an un-
likely candidate to explain the massive H4K16 hyperacety-
lation observed in peripheral neutrophils. We therefore pos-
tulated the hypothesis that this epigenetic changemight play
a role in neutrophil apoptosis. Indeed, it has been previously
shown that H4K16ac is involved in the regulation of apop-
totic genes in leukemia cancer cells (18).
To study the role of H4K16ac in apoptosis in myeloid
cells in more detail, we first analyzed H4K16ac changes
during HL60 cell culture. These cells have previously been
shown to undergo spontaneous apoptosis in a cell-density
dependent fashion (67). HPLC/HPCE and tandem mass
spectrometry experiments carried out here showed that
global H4K16ac increased with cell density until the cells
reached confluence (day 5), after which it stabilized at∼35%
(Figure 4A and B, Supplementary Figure S9a). Interest-
ingly, the highest H4K16ac levels coincided with the in-
duction of spontaneous apoptosis (day 5) (Figure 4A).
H4K16ac has been shown to fluctuate during the cell cy-
cle, peaking during the S phase, and reaching its lowest lev-
els in the G2/M phase (68). To determine any possible ef-
fect of the cell cycle on changes in H4K16ac during the
increase in cell confluence we analyzed the percentage of
cells in each phase of the cycle in the assay previously de-
scribed. The results showed a negative correlation between
global H4K16ac and the percentage of cells in either the S
or theG2/Mphase during exponential cell growth (Pearson
Correlation coefficient = –0.770, P-value = 0.025; Pearson
Correlation coefficient = –0.714, P-value = 0.047, respec-
tively), but no clear associations following the induction of
apoptosis (Supplementary Figure S9B). Taken together our
findings lead us to discard the notion that the cell cycle has
any marked effect on the cell-density dependent increase in
H4K16ac.
The association between H4K16ac and apoptosis led
us to study the possible role of this epigenetic mark in
programmed cell death in more detail. We first analyzed
the levels of apoptosis in undifferentiated vs. differentiated
HL60 cells which were either untreated or treated with
suberoylanilide hydroxamic acid (SAHA) (Supplementary
Figure S9C), an inhibitor of the H4K16 histone deacety-
lases HDAC1 and HDAC2 (69). Treatment with SAHA in-
creased monoacetylated histone H4 from 33% to 56% in
control HL60, and to 60% in HL60 cells differentiated with
ATRA+DMSO (Figure 4C; Supplementary Figure S9D).
Interestingly, incubation with SAHA also increased apop-
tosis in HL60 cells, with a more pronounced effect in differ-
entiated cells (Figure 4C).
Histone deacetylase inhibitors can induce acetylation
changes at positions other than H4K16 (69).
In order to establish the particular role of global
H4K16ac in apoptosis, we ectopically regulated the levels of
the H4K16-specific histone acetyltransferase KAT8 in both
human primary cells and mouse cells. Firstly, we knocked
down KAT8 (shKAT8) in human CD34+ progenitors from
umbilical cord blood and thenwe induced neutrophil differ-
entiation (Figure 4D). Six days after the induction of neu-
trophil differentiation, between 50 and 60% of scramble and
shKAT8 cells were positive for CD33 and CD15 (data not
shown). shKAT8 reduced H4K16 acetylation (Figure 4D),
and Annexin V-7AAD staining at days 8–11 revealed a de-
crease in apoptosis in cells with lower KAT8/H4K16ac lev-
els (Figure 4E).
Next, we used the in vitro model of neutrophil differen-
tiation on murine cKit+ progenitors from the Kat8 con-
ditional knockout mouse (Figure 3) to analyze neutrophil
apoptosis with and without staurosporine treatment, which
is known to be an apoptosis inductor. Analysis of the
Annexin V-7AAD staining of differentiated neutrophils at
day 7 revealed that apoptosis levels were similar in con-
trol and Kat8 knockout-derived cells, both with (85.98%
and 87.76%, respectively) andwithout (26.81% and 25.96%,
respectively) staurosporine treatment (Supplementary Fig-
ure S10). Within each treatment there were, however, dif-
ferences between control and Kat8 knockout-derived cells
in their distribution between the early and late phases of
apoptosis. Without staurosporine, late apoptosis was de-
tected in 4.61% of control cells but in only 2.26% of Kat8
knockout-derived cells. Similarly, after treatment with stau-
rosporine we found 8.23% of control cells to be in the late
apoptosis phase and only 5.56% of Kat8 knockout-derived
cells (Supplementary Figure S10). Thus, these results indi-
cate that Kat8 downregulation in murine cKit+ progenitor-
derived neutrophils induces a slight retardation of entry into
the late apoptosis phase, both in the presence and absence
of staurosporine (Supplementary Figure S10).
To further study the relationship between global H4K16
acetylation and apoptosis, we treated the cancer cell line
HL60 with the topoisomerase inhibitor etoposide (Supple-
mentary Figure S11A), which has been shown to induce
apoptosis in myeloid tumors (70). Additionally, H4K16
acetylation was modulated by treating HL60 cells with ei-
ther SAHA or KAT8 interference or upregulation (Supple-
mentary Figure S11B and C). Etoposide has been demon-
strated to induce an apoptosis that cannot be measured by
Annexin V staining in HL60 due to the compound’s lipid
anti-oxidant action, which inhibits phosphatidylserine ex-
ternalization and, therefore, its staining (71). For this rea-
son, although we measured both Annexin V+ cells and de-
bris percentages (from Propidium Iodide staining), only de-
bris values account for etoposide-induced apoptosis. We
observed that, when incubation was with etoposide alone,
there was induction of apoptosis which was independent
of any increase in H4K16ac (Supplementary Figure S11A).
Indeed, after 4 h of incubation with the topoisomerase in-
hibitor there was even a small decrease in acetylation, which
is in line with previously published data (72). When cells
were treated with SAHA, there were initial (i.e. prior to
etoposide incubation) high levels of Annexin V+ apopto-
sis, but these decreased over time during etoposide treat-
ment. As the accompanying increase in debris percentages
could be explained by the fragmentation of Annexin V+
dying cells, it can be seen that etoposide-induced apopto-
sis does not seem to change with SAHA treatment (Sup-
plementary Figure S11c). Taken together, these data sug-
gest that H4K16ac is not essential for the induction of pro-
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Figure 4. Association between global levels of H4K16ac and apoptosis in myeloid cells. (A) Global H4 monoacetylation analyzed by HPLC and HPCE
(blue bars in the upper panel), and percentage of Annexin+ cells (lower panel) during HL60 cell increasing confluence (black line). (B) Representative
immunofluorescence images showing the changes in H4K16ac during the exponential growth of the cells at days 2 and 8. (C) Bar plots showing the effects
of the treatment with SAHA in control and in vitro differentiated HL60 cells. Upper panel depicts the effects of the treatment onH4monoacetylation levels,
and lower panels, the effect on apoptosis measured by Annexin V-7AAD staining and percentage of debris from Propidium Iodide staining. A: ATRA, D:
DMSO, S: SAHA. (D) RT-qPCR showing downregulation of KAT8 in transduced CD34+ progenitors. Expression levels determined by real time-qPCR
are an average of triplicated measurements (+SD), normalized to transcript levels of GAPDH, and represented as a fold-change relative to the scramble.
Below, a western blot comparing H4K16ac in shKAT8 cells versus the scramble. H3 was used as loading control. The intensity (relative units) of H4K16ac
bands were normalized to H3 and quantified using ImageJ software (numbers below the bands). On the right, representative immunofluorescence images
showing lower levels of H4K16ac in shKAT8 cells at day 11. Average H4K16ac fluorescence intensity was quantified using ZEN lite software (a t-test
showed significant differences; **P < 0.001). (E) Bar plots showing the lower percentage of apoptosis of shKAT8 cells. Apoptosis levels were assessed by
Annexin V-7AAD staining.
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grammed cell death, and that basal H4K16 acetylation level
is sufficient for programmed cell death to occur. In line with
this, KAT8 over expression did not affect the apoptosis in-
duced by etoposide. However, ectopic downregulation of
KAT8 inHL60 cells was associated with reduced etoposide-
induced cell death at 3h of treatment (Supplementary Fig-
ure S11C).
In order to explore the possible connection between the
cell death detected in HL60 cells in our study and the gen-
eration of neutrophil extracellular traps (NETs) (73), we
tested the NETosis of HL60 cells under different condi-
tions: treated or not with SAHA, and after the induction
of ectopic up- or downregulation of KAT8. In all the con-
ditions analyzed, the levels of elastase activity, as ameasure-
ment ofNETs formation, were similar to background signal
(Supplementary Figure S12). It would thus seem that, under
these conditions, NETosis is not induced.
Enrichment of H4K16ac at specific repeated DNA in neu-
trophils
As the H4K16ac changes in differentiation and apopto-
sis genes between lymphoid and myeloid cells were un-
likely to explain the global differences observed by mass
spectrometry (>20% of the genome), we reanalyzed our
ChIP-seq data of CD3+ T cells and neutrophils to iden-
tify the DNA regions where these changes occur. To this
end we focused our attention on repetitive DNA, a type of
DNA sequence that is not usually given much attention in
ChIP-seq experiments because they are difficult to map in
the genome. Interestingly, the HOMER enrichment anal-
yses showed that H4K16ac peaks, overlapped with specific
repetitive sequences in the genome in bothCD3+ T cells and
neutrophils (Supplementary Tables S3 and S4). To further
investigate these relationships we carried out a comparative
statistical analysis of H4K16ac enrichment in three types
of repetitive sequence identified in the ChIP-seq: Short In-
terspersed Nuclear Elements (SINEs), Long Interspersed
Nuclear Elements (LINEs) and Satellites. These analyses
showed that the H4K16ac peaks of neutrophils were signif-
icantly enriched in SINEs (Permutation test, P < 0.01, FC
CI= [1.34, 1.42]), while being depleted in LINEs (Permuta-
tion test, P< 0.01, FC CI = [0.61, 0.63]) and satellites (per-
mutation test, P < 0.01, FC CI = [0.26, 0.38]). Conversely,
H4K16ac peaks of CD3+ T cells were significantly depleted
in SINEs (Permutation test, P< 0.01, FC CI= [0.70, 0.72])
(Figure 5A, upper panels). The analyses of specific families
of repetitive elements showed that H4K16ac peaks of neu-
trophils were significantly enriched in Alu elements (Homer
Genome test, P < 0.001, logRE = 0.50), mammalian-wide
interspersed repeat (MIR) sequences (Homer Genome test,
P < 0.001, logRE = 0.45), and LINE-2 (Homer Genome
test, P < 0.001, logRE = 0.28), but depleted in LINE-
1 and satellites (Homer Genome test, P < 0.001, logRE
= –0.85 and P < 0.001, logRE = –1.11, respectively). In
contrast, H4K16ac peaks of CD3+ T cells were signifi-
cantly depleted in Alu sequences (Homer Genome test, P
< 0.001, logRE = –0.57) (Figure 5A, lower panels). Simi-
lar results were obtained in four additional independet bi-
ological replicates, although in the case of CD3+ T cells we
observed some interindividual variability (Supplementary
Figure S13). Enrichment analysis of different repeat fami-
lies across the chromatin states (Figure 5B) confirmed that
H4K16ac peaks (emission order 10) specific for neutrophils
(Figure 2F) are enriched in Alu repeats, MIR and LINE 2.
Interestingly, although in the analyses of the ‘unique
mapped reads’ we identified a significant overlap of
H4K16ac peaks with several types of repetitive sequences
(Figure 5A and Supplementary Figure S13A), we also iden-
tified that the regions flanking the peaks in both cell types
were highly enriched in repetitive elements (Figure 5C), sug-
gesting that H4K16ac could be evenmore enriched in repet-
itive elements than initially revealed, though this would be
masked by the limitation of the computational method em-
ployed to deal with ambiguous reads and detect enrichment
of peaks in those regions. We also found similar results in 4
additional independet biological replicates (Supplementary
Figure S13B).
To investigate this further we carried out a new anal-
ysis of the ‘ambiguous reads’, that is, those that align in
multiple parts of the genome and could in theory be as-
sociated with repetitive regions (Supplementary Table S2)
(see Materials and Methods). In line with the results ob-
tained with the unambiguosly mapped reads, this approach
showed that neutrophil H4K16ac peaks were enriched in
SINEs (particularly Alu sequences) (Homer Genome test,
P< 0.001, logRE= 0.1) and LINE-2 (Homer Genome test,
P < 0.001, logRE = 0.03), but depleted in LINE-1 (Homer
Genome test,P< 0.001, logRE= –0.12) and in centromeric
repeats (Homer Genome test, P < 0.001, logRE = –0.15)
(Figure 5D). Similar results were obtained in 4 additional
independent biological replicates, although in the case of
CD3+ T cells we observed some interindividual variability
(Supplementary Figure S14). Collectively these results in-
dicate that, in neutrophils, H4K16ac is enriched at specific
repeated DNA regions.
H4K16ac-rich DNA repeats mark genomic regions frag-
mented early on in neutrophil apoptosis
As H4K16ac has been proposed to play an important role
inmaking chromatin accessible inDNA repair (37), we con-
sidered it reasonable to assume that it could also play a
similar role in DNA cleavage during neutrophil apoptosis.
In the first stages of the apoptotic process, genomic DNA
is cleaved into 300 and 50 kb fragments (74). Therefore,
to study the possible role of global H4K16 hyperacetyla-
tion in early DNA fragmentation during neutrophil apop-
tosis, we determined whether the genomic regions specifi-
cally enriched in H4K16ac in neutrophils were fragmented
during the early stages of neutrophil apoptosis. Our ChIP-
seq data suggested that the global H4K16 hyperacetyla-
tion observed in neutrophils by mass spectrometry is, at
least in part, due to the increase of this histone modifica-
tion at specific repeated DNA regions (Figure 5). We thus
designed PCR oligonucleotides against 6 of these regions
(Supplementary Table S1) and used them to amplify the
50 kb DNA fragments isolated by pulsed field gel elec-
trophoresis (Figure 6A; Supplementary Figure S15A, B)
from apoptotic neutrophils obtained from two independent
series of healthy individuals (Figure 6B; Supplementary
Figure S15C). Bisulfite pyrosequencing analysis of these ge-
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Figure 5. Distribution ofH4K16 acetylation at specific repetitiveDNAelements in neutrophils andCD3+ T cells. (A) Bar plots showing the overlap between
H4K16-enriched peaks and different types of DNA repeats, obtained in the analyses of unique mapped reads. Violin plots represent a permutation-based
null distribution for each type of repeated DNA overlap ratio for each peak data set. Lower panels show associations between different types of repetitive
DNA elements with H4K16ac peaks in neutrophils and CD3+ T cells, ranked by Q-value, and enrichment score (relative risk). (B) Enrichment of the 12
chromatin states described in Figure 2F in different types of DNA repeats. (C) Plot showing the coverage of repetitive elements in the regions flanking
the H4K16ac enriched peaks obtained in the analyses of unique mapped reads in both cell types. (D) Stacked bar charts describing the classification of
ambiguous reads for neutrophil and CD3+ T cell signals relative to the corresponding input, and according to the enrichment in different types of DNA
repeats. Lower panels show associations between different types of repetitive DNA elements with probable H4K16ac-enriched regions obtained from
ambiguous mapping in neutrophils and CD3+ T cells, and ranked by Q-value, and enrichment score (relative risk).
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Figure 6. Associations between H4K16ac enriched regions and DNA breakage during neutrophil apoptosis. (A) Schematic representation of the pulsed-
field gel electrophoresis (PFGE) experiment to analyze the 50 kbDNA fragments from apoptotic neutrophils. (B) qPCR amplification of specificH4K16ac-
enriched repeats using the 50kb DNA fragments from the PFGE. Data are an average of triplicated measurements, normalized to a H4K16ac-poor region
of the albumin gene, and represented as a fold-change relative to the 50kb sonicatedDNA. Intact DNA and 50kb random fragments from a pool of samples
were used as positive controls. H4K16ac peaks identified by MACS2, and genome diagrams showing the relative enrichment of H4K16ac in neutrophils
(blue), and CD3+ T cells (green) are shown on the left. Significant H4K16ac peaks showing fold change above 1.5 are indicated by a colored bar below the
profile.
nomic regions showed that they are highly hypermethylated
in both neutrophils and CD3+ T cells (Supplementary Fig-
ure S16). As a negative control, we used oligonucleotides
designed against DNA regions lacking H4K16ac in neu-
trophils (Supplementary Table S1). The oligonucleotides
designed against H4K16ac-poor DNA regions amplified
both the early apoptotic 50 kb DNA fragments isolated by
pulsed field gel electrophoresis and unspecific 50 kb frag-
ments generated by sonication (Figure 6B; Supplementary
Figure S15C). In contrast, the oligonucleotides designed
against the H4K16ac-rich DNA repeats amplified the un-
specific 50 kb DNA fragments to a far greater extent than
the early DNA apoptotic 50 kb DNA fragments isolated by
pulsed field gel electrophoresis (Figure 6B; Supplementary
Figure S15C), which indicates that H4K16ac is enriched in
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the DNA fragments generated during the early stages of
neutrophil apoptosis.
Finally, to study the possible effect of H4K16 hyperacety-
lation at these DNA repeats on the chromatin conforma-
tion state we took two different approaches. First, we used
an H4K16ac-specific antibody to determine by immunoflu-
orescence the enrichment of this histone PTM in the nu-
clear regions of human neutrophils and CD3+ T cells (Fig-
ure 7A). As expected, DAPI staining was very different be-
tween lymphoid and myeloid cells. Neutrophils displayed
large blocks of highly compacted heterochromatin in the
nuclear periphery. These blocks were separated by regions
of mildly compact chromatin and the least compacted chro-
matin was in the center of the nucleus (Figure 7A). In con-
trast, CD3+ cells showed a more uniform chromatin com-
paction pattern, with only a few small blocks of heterochro-
matin attached to the nuclear periphery. H4K16ac stain-
ing was almost completely absent from the large blocks of
heterochromatin of the neutrophil nuclear envelop (Figure
7A, B) and, interestingly, although the low compacted chro-
matin areas of the center of the nucleus were stained, the
highestH4K16ac signal was observed in themildly compact
chromatin regions interspersed between the large blocks of
heterochromatin of the nuclear periphery (Figure 7A, B).
In CD3+ cells, H4K16ac staining was similar to that re-
ported in other cell types and was far more uniform than
in neutrophils (Figure 7A, B). Generally, H4K16ac stain-
ing and DAPI were less correlated in neutrophils than in in
CD3+ (Pearson correlation = 0.03 and 0.68, respectively)
(Figure 7B; Supplementary Table S10). In the second ap-
proach, we used a chromatin accessibility assay, based on
how accessible the DNA is to nucleases, to determine the
level of chromatin compaction in six of the previously iden-
tified H4K16ac-rich repeats which are fragmented at early
stages of neutrophil apoptosis (Alu 257398, Alu 257394,
L2 12327, L2 100294, Sat 101966 and Sat 28530) in neu-
trophils and CD3+ cells obtained from four healthy individ-
uals. We further validated these results by FAIRE quanti-
tative PCR (FAIRE-qPCR) analysis (Supplementary Fig-
ure S17). In general, there was considerable interindivid-
ual variability for most of the sequences analyzed in both
myeloid and CD3+ cells. However, chromatin was always
more accessible in neutrophils than in CD3+ in all the re-
peated DNA regions analyzed (Figure 7C; Supplementary
Figure S17).
DISCUSSION
Neutrophils are defined by their multilobed nuclear archi-
tecture (75), and they display a characteristic pattern of
histone PTMs (76). Our initial observation that human
PB neutrophils are hyperacetylated at H4K16 as compared
with other terminally differentiated types of blood cells led
us to investigate the role of this histone PTM in myeloid
cells in more detail. Genome-wide mapping of H4K16ac
in peripheral neutrophils and CD3+ T cells confirmed its
enrichment in the myeloid lineage. The results obtained in
vitro and in vivo in this work suggest that this PTM plays an
important role in blood cell survival and hematopoietic dif-
ferentiation, and they are in line with other previous results
showing the critical importance of KAT8 and H4K16ac in
these processes (77,78).
Although our results supported a role for H4K16ac in
gene regulation during cell differentiation, such changes in
the small number of genes involved in cell differentiation
are insufficient to explain the massive global differences be-
tween neutrophils and CD3+ T cells observed by mass spec-
trometry that affects >20% of the genome. It has been re-
ported that mice lacking a processing protease of the nu-
clear envelope protein laminA show a low level ofH4K16ac
(79,80). However, Pelger-Hue¨t patients, who have lamin B
mutations, and individuals with myelodysplastic syndrome,
who presentwith an altered neutrophil nuclearmorphology,
have a normal distribution of H4K16ac (data not shown),
suggesting that this histone PTM does not play a central
role in these disease processes. Future research is needed to
determine the biological consequences, if any, of the alter-
ations of H4K16ac inZmpste24mutant mice, which are de-
ficient in the proteolytic processing of prelamin A.
Previous findings have also suggested that H4K16ac also
plays an important role in gene regulation during pro-
grammed cell death (17,18). Interestingly, we found a corre-
lation and a functional association between H4K16ac and
apoptosis in HL60 cells and in neutrophils obtained by in
vitro myeloid differentiation of CD34+ mouse and human
progenitors, providing further support for this histonemod-
ification having a role in the process. However, as previ-
ously stated with respect to the cell differentiation genes,
differences in H4K16ac in a few apoptotic genes cannot
explain the massive genome-wide H4K16 hyperacetylation
observed in peripheral blood neutrophils. Indeed, in vitro
differentiated neutrophils do not display the same global
H4K16 hyperacetylation and staining pattern as that ob-
served in peripheral blood neutrophils, something which
should be taken into account in future studies using such
in vitro models.
We next therefore considered the possibility that, in ad-
dition to gene regulation, H4K16ac plays another role in
neutrophil apoptosis. The magnitude of the differences and
the enrichment of H4K16ac in specific repeated DNA se-
quences in neutrophils pointed to a structural role for this
histone modification in the process. In line with this, our
results revealed an enrichment of this histone mark in re-
gions associatedwith earlyDNA fragmentation during neu-
trophil apoptosis. We also showed that these DNA regions
are more accessible in this cell type than in CD3+ T cells,
intimating that H4K16ac plays a role in the establishment
of a specific chromatin status that facilitates DNA frag-
mentation early during apoptosis. In support of this no-
tion, in vitro experiments with nucleosomal arrays and com-
putational modeling have shown that acetylation at lysine
16 of histone H4 plays a central role in the regulation of
higher-order chromatin structure and the interactions be-
tween non-histone proteins and chromatin fiber (14,81,82).
However, the relationship between chromatin structure and
H4K16ac is far more complex, because, in vivo, this his-
tonemodificationwas also found to be associatedwith com-
pacted chromatin and repression (83), and loss of H4K16ac
does not alter higher-order chromatin compaction inmouse
embryonic stem cells (84). In line with this, although we ob-
served the clear exclusion ofH4K16ac from the large blocks
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Figure 7. Effect of H4K16ac enrichment at the repeated DNA fragmented early in neutrophil apoptosis. (A) Representative immunofluorescence images
of nuclear distribution of H4K16ac in neutrophils and CD3+ T cells. On the right, line plots comparing DAPI and H4K16ac staining signals in several
nuclear longitudinal positions. The red lines in the merged images indicates the position and direction of measurements. (B) Heat density scatterplots
depicting the different distribution of the H4K16ac signal with respect to DAPI intensity in neutrophils (n = 72 cells from five donors) (upper panel) and
CD3+ T cells (n = 62 cells from one donor) (lower panel) performed with 9198 and 5925 pairwise datapoints respectively. Colors represent the relative
density of the number of measurements (data points) obtained across the different axes (blue – low density areas, red – high density areas). H4K16ac and
DAPI intensities were positively correlated in lymphocyte cells (pcorr = 0.68), whereas neutrophils displayed a more sparse, non-correlated distribution
(pcorr = 0.03) of H4K16ac-DAPI signals across the nucleus. (C) Chromatin accessibility assay in four donors showing that H4K16ac-enriched repetitive
sequences in neutrophils are more associated with open chromatin than in CD3+ T cells. %FE: fold enrichment percentage.
of heterochromatin of the nuclear periphery of peripheral
blood neutrophils, we did not find any global correlation
between this epigenetic modification and nuclear chromatin
compaction in this type of cells. These data thus suggest that
H4K16ac function in chromatin conformation may well be
highly dependent on the type of chromatin region and, con-
sequently, this should be explored further.
Although the genomic regions targeted during the apop-
totic early DNA fragmentation are still poorly understood,
it has been proposed that the cleavage might occur prefer-
entially at repeated DNA (85) and in regions of accessible
chromatin (86). Thus, it is possible that hyperacetylation of
H4K16 at specific repeatedDNA regions establishes a char-
acteristic chromatin structure/state prone to DNA frag-
mentation during apoptosis in neutrophils specifically. In-
terestingly, H4K16ac-mediated chromatin relaxation might
facilitate DNA repair of double-strand breaks (79). Taken
together, these results could imply that chromatin relaxation
by H4K16 acetylation plays a general role in DNA cleav-
age during programmed cell death, a possibility that should
be studied in more detail in the future. Moreover, both the
H4K16ac-rich repeats cleaved during the first stages of neu-
trophil apoptosis and the chromatin state specifically en-
riched in this histone PTM in neutrophils (state 10) are
enriched in hypermethylated DNA. Thus, future research
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should also determine the role of this latter chromatin state
in the DNA cleavage occurring early on during apoptosis.
In summary, our study is in line with previous liter-
ature showing a positive correlation between high lev-
els of H4K16ac and apoptosis (17,18,34,35), which sug-
gests that H4K16 hyperacetylation is directly involved in
programmed cell death. However, our experiments which
showed a lack of global H4K16 hyperacetylation in apop-
tosis cell death induced by etoposide in myeloid cells indi-
cate either that the non-canonical structural role of this hi-
stone PTM that is described in this manuscript is not essen-
tial to induce programmed cell death, or that basal levels of
H4K16ac might be sufficient. Making the story even more
complex, our data shows that ectopic downregulation of
KAT8 reduced etoposide-induced cell death in HL60 cells,
which suggests that this histonemodification could still play
a role in the process. For example, downregulation of KAT8
might impair the H4K16ac-dependent upregulation of spe-
cific proapoptotic genes, which is compatible with the fact
that the downregulation of KAT8 in this work only induced
a relatively small decrease in H4K16ac. A possible canon-
ical role for H4K16ac in the regulation of apoptotic genes
in HL60 cells exposed to etoposide is also compatible with
the lack of global changes of H4K16ac in HL60 exposed
to etoposide because, as previously reasoned, changes in
this histonemodification at a small number of specific genes
would not be expected to be detected at a global level. Fi-
nally, it could also be possible that the effect ofKAT8 down-
regulation in HL60 cells treated with etoposide in fact im-
pacts on the role of this histone acetyltransferase in the
modulation of other regulators of apoptosis (87). Further
research is thus still needed to determine the precise roles
of KAT8 and H4K16ac in etoposide-induced cell death in
HL60 cells.
Further research will also be needed to determine
whether H4K16 hyperacetylation is required for apopto-
sis in other cell types. However, the fact that H4K16 hy-
poacetylation underpins resistance to the topoisomerase I
inhibitor irinotecan in colon cancer cells lends support to
the notion that this histone modification might play a gen-
eral role in apoptosis (35). Interestingly, our results showed
that tumoral HL60 cells have lower H4K16 acetylation
levels than their non-tumorigenic terminally differentiated
peripheral blood cell counterparts (Supplementary Figure
S8A), which is in line with previously published data show-
ing that H4K16ac is frequently down-regulated in cancer
(21–24), although the underlying molecular mechanisms
were largely unclear. Our results suggest that myeloid tu-
mors display low H4K16ac levels, because they do not un-
dergo the massive hyperacetylation that occurs during the
last stages of myeloid differentiation. Moreover, the lack
of H4K16 hyperacetylation could even favor the resistance
of these tumor cells to apoptosis, one of the hallmarks of
cancer (88). In line with this, our results might help to un-
derstand the mechanism of action of HDAC inhibitors, a
family of small molecules with antitumor activity that can
induce histone hyperacetylation and apoptosis in myeloid
cells (88). Although it was proposed that their mechanism
of action is mediated, at least in part through the reac-
tivation of proapoptotic genes (18,89), these compounds
have many pleiotropic effects and their mechanism of ac-
tion is still poorly understood. Our data suggest that, in ad-
dition to gene regulation, HDAC inhibitors might also pro-
mote programmed cell death through the establishment of a
higher-order chromatin structure prone to DNA fragmen-
tation during the first stages of apoptosis. In support of this
notion, we observed that the treatment of the HL60 cancer
cell line with SAHA increased H4K16ac levels at specific
DNA repetitive regions identified in our ChIP-seq (Supple-
mentary Figure S18). As this possibility could have impor-
tant clinical implications, future research is needed to con-
firm the role of H4K16 hyperacetylation of repeated DNA
on the mechanism of HDAC inhibitor treatment of cancer.
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